Diet Quality and Diabetes Risk in Overweight and Obese Adults

September 24, 2024 updated by: Rahime Evra KARAKAYA, Ankara Yildirim Beyazıt University

The Relationship Between Sociodemographic Characteristics, Lifestyle, and Diet Quality With Diabetes Risk in Overweight and Obese Adults

The goal of this observational study is to learn about the relationship between diabetes risk with sociodemographic characteristics, lifestyle and diet quality in overweight and obese individuals. The main question it aims to answer is:

Is there a relationship between diabetes risk and diet quality in overweight and obese individuals?

Participants who are overweight and obese will answer survey questions about sociodemographic characteristics and lifestyle behaviors. 24 hour dietary recalls will be taken to evaluate diet quality. FINDRISC questionnaire will be applied to assess diabetes risk.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

1840

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Çubuk
      • Ankara, Çubuk, Turkey, 06760
        • Ankara Yıldırım Beyazıt University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Community sample in Ankara, Turkey

Description

Inclusion Criteria:

  • Body mass index (BMI) ≥25 kg/m²

Exclusion Criteria:

  • Diabetes mellitus
  • Psychiatric disorders
  • Pregnant and lactating

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adults
Overweight and obese adults
Behavioral: Questionnaire and anthropometric measurement
Questionnaire including sociodemographic characteristics, lifestyle habits, body weight, height, dietary assessment and diabetes risk; Anthropometric measurement including waist circumference

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Finnish Diabetes Risk Score (FINDRISC)
Time Frame: Baseline
Scores can range from a minimum of 0 to a maximum of 26 points. According to the FINDRISC scoring system, scores are classified as follows: a score of less than 7 indicates low risk, 7-11 indicates mild risk, 12-14 indicates moderate risk, 15-20 indicates high risk, and a score of less than 20 indicates very high risk.
Baseline
Healthy eating index-2015 (HEI-2015)
Time Frame: Baseline
A 24 hour dietary recall was used to assess dietary intake. Nutrient intake obtained from dietary recalls were evaluated using Ebispro for Windows, Stuttgart, Germany; Turkish Version (BeBiS 9). The HEI- 2015 and its sub-scores are calculated based on the quantity of food and nutrient intake per 1,000 kilocalories consumed by individuals. HEI-2015 scores range from a minimum of 0 to a maximum of 100. Based on the calculated scores, a score greater than 80 indicates good diet quality, a score between 51 and 80 is categorized as moderate diet quality, and a score of 50 or less is defined as poor diet quality.
Baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight
Time Frame: Baseline
Body weight in kg
Baseline
Height
Time Frame: Baseline
Height in cm
Baseline
Sociodemographic characteristics
Time Frame: Baseline
number and percentage
Baseline
Lifestyle habits
Time Frame: Baseline
number and percentage
Baseline
Waist circumference
Time Frame: Baseline
waist circumference in cm
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ankara Yildirim Beyazıt University

Investigators

  • Principal Investigator: Rahime E Karakaya, PhD, Ankara Yildirim Beyazıt University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2024

Primary Completion (Actual)

June 15, 2024

Study Completion (Actual)

June 15, 2024

Study Registration Dates

First Submitted

September 20, 2024

First Submitted That Met QC Criteria

September 24, 2024

First Posted (Actual)

September 26, 2024

Study Record Updates

Last Update Posted (Actual)

September 26, 2024

Last Update Submitted That Met QC Criteria

September 24, 2024

Last Verified

September 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AnkaraYBU-KARAKAYA002

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obesity

Clinical Trials on Questionnaire and anthropometric measurement

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Peru

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe